Skip to content

Erasca, Inc. ERAS Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Eli Lilly logo
Eli LillyLLY
3.1%+1.6pp
Pfizer logo
PfizerPFE
6.8%
Amgen logo
AmgenAMGN
4.1%+0.6pp
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-7.1%-1.8pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-3.6%-1.8pp

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Calculated from Erasca, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s earnings yield?
Erasca, Inc. (ERAS) reported earnings yield of -5.5% in Q1 2026.
How has Erasca, Inc.'s earnings yield changed year-over-year?
Erasca, Inc.'s earnings yield increased by 86.4% year-over-year, from -40.6% to -5.5%.
What is the long-term trend for Erasca, Inc.'s earnings yield?
Over 4 years (2021 to 2025), Erasca, Inc.'s earnings yield has grown at a 29.6% compound annual growth rate (CAGR), from -4.2% to -11.8%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.